MTHFD2 and cancer: Thus, the development of selective MTHFD2 inhibitorscould present a novel and promising therapeutic strategy for MTHFD2-overexpressingcancers with minimal side effects.10 Despitenotable expression of MTHFD2 in various cancer types, only a few MTHFD1/2dual inhibitors have been identified.